Creative Planning’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.15M | Sell |
15,387
-645
| -4% | -$298K | ﹤0.01% | 1034 |
|
|
2026
Q1 | $7.7M | Sell |
16,032
-1,476
| -8% | -$756K | 0.01% | 868 |
|
|
2025
Q4 | $9.83M | Buy |
17,508
+5,702
| +48% | +$3.24M | 0.01% | 629 |
|
|
2025
Q3 | $6.07M | Buy |
11,806
+6,327
| +115% | +$2.76M | ﹤0.01% | 767 |
|
|
2025
Q2 | $1.72M | Buy |
5,479
+141
| +3% | +$42.3K | ﹤0.01% | 1442 |
|
|
2025
Q1 | $1.63M | Buy |
5,338
+521
| +11% | +$175K | ﹤0.01% | 1343 |
|
|
2024
Q4 | $1.6M | Buy |
4,817
+202
| +4% | +$68.5K | ﹤0.01% | 1283 |
|
|
2024
Q3 | $1.54M | Sell |
4,615
-47
| -1% | -$17.9K | ﹤0.01% | 1221 |
|
|
2024
Q2 | $1.92M | Sell |
4,662
-59
| -1% | -$23.4K | ﹤0.01% | 1008 |
|
|
2024
Q1 | $1.91M | Sell |
4,721
-5,221
| -53% | -$1.84M | ﹤0.01% | 980 |
|
|
2023
Q4 | $3.05M | Buy |
9,942
+510
| +5% | +$138K | 0.01% | 736 |
|
|
2023
Q3 | $2.28M | Buy |
9,432
+85
| +0.9% | +$21.7K | ﹤0.01% | 803 |
|
|
2023
Q2 | $2.24M | Buy |
9,347
+1,146
| +14% | +$238K | ﹤0.01% | 762 |
|
|
2023
Q1 | $1.54M | Buy |
8,201
+1,798
| +28% | +$372K | ﹤0.01% | 888 |
|
|
2022
Q4 | $1.36M | Buy |
6,403
+1,454
| +29% | +$290K | ﹤0.01% | 892 |
|
|
2022
Q3 | $778K | Buy |
4,949
+1,839
| +59% | +$293K | ﹤0.01% | 1077 |
|
|
2022
Q2 | $465K | Buy |
3,110
+58
| +2% | +$8.4K | ﹤0.01% | 1364 |
|
|
2022
Q1 | $499K | Buy |
3,052
+10
| +0.3% | +$1.65K | ﹤0.01% | 1322 |
|
|
2021
Q4 | $662K | Buy |
3,042
+32
| +1% | +$6.7K | ﹤0.01% | 1153 |
|
|
2021
Q3 | $570K | Buy |
3,010
+2
| +0.1% | +$365 | ﹤0.01% | 1221 |
|
|
2021
Q2 | $531K | Sell |
3,008
-803
| -21% | -$139K | ﹤0.01% | 1246 |
|
|
2021
Q1 | $625K | Buy |
3,811
+854
| +29% | +$131K | ﹤0.01% | 1283 |
|
|
2020
Q4 | $412K | Buy |
2,957
+20
| +0.7% | +$2.52K | ﹤0.01% | 1427 |
|
|
2020
Q3 | $328K | Buy |
+2,937
| New | +$340K | ﹤0.01% | 1361 |
|
|
2017
Q4 | – | Sell |
-6,675
| Closed | -$213K | – | 1964 |
|
|
2017
Q3 | $213K | Buy |
6,675
+6,672
| +222,400% | +$204K | ﹤0.01% | 1568 |
|
|
2017
Q2 | $0 | Buy |
+3
| New | +$84 | ﹤0.01% | 4743 |
|
|
2017
Q1 | – | Sell |
-32
| Closed | -$1K | – | 4811 |
|
|
2016
Q4 | $1K | Sell |
32
-4,316
| -99% | -$144K | ﹤0.01% | 4457 |
|
|
2016
Q3 | $130K | Buy |
+4,348
| New | +$127K | ﹤0.01% | 1664 |
|
Other funds holding MEDP
WA
Creative Planning's MEDP Position: Q2 2026 in Review
Creative Planning reduced its Medpace (MEDP) stake by 4% in Q2 2026, selling an estimated $298K and leaving 15,387 shares worth $8.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1034.
Creative Planning first reported a position in MEDP in Q3 2016 and has held it in 28 quarters since. The position peaked at $9.83M in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Creative Planning held 15,387 shares of Medpace worth $8.15M as of Q2 2026.
- Creative Planning sold 645 Medpace shares in Q2 2026, an estimated $298K.
- Medpace made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #1034 holding.
- Creative Planning first reported a position in Medpace in Q3 2016 and has held it in 28 quarters since.
- Creative Planning's Medpace position peaked at $9.83M in Q4 2025.
- 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.